- Is Damon Runyon Cancer Research Foundation Inc a tax-exempt 501(c)(3)?
- Yes. Damon Runyon Cancer Research Foundation Inc is recognised by the IRS as a 501(c)(3) organisation (EIN 13-1933825). The IRS recognised Damon Runyon Cancer Research Foundation Inc as tax-exempt in June 1947.
- What is Damon Runyon Cancer Research Foundation Inc's EIN?
- Damon Runyon Cancer Research Foundation Inc's Employer Identification Number (EIN) is 13-1933825. The EIN was assigned by the IRS in June 1947. Donors and grantmakers use the EIN to verify tax-exempt status with the IRS.
- What does Damon Runyon Cancer Research Foundation Inc do?
- Accelerating breakthroughs by funding the most innovative young cancer researchers.
- Where is Damon Runyon Cancer Research Foundation Inc located?
- Damon Runyon Cancer Research Foundation Inc is located at 55 Broadway 302, New York, NY, 10006.
- When was Damon Runyon Cancer Research Foundation Inc founded or recognised by the IRS?
- Damon Runyon Cancer Research Foundation Inc was recognised by the IRS as a tax-exempt organisation in June 1947. The IRS ruling date is the earliest authoritative date available for most US nonprofits.
- What is Damon Runyon Cancer Research Foundation Inc's annual revenue?
- On its most recent Form 990 (fiscal year 2024), Damon Runyon Cancer Research Foundation Inc reported $54.7M in total revenue and $25.1M in total expenses.
- Has Damon Runyon Cancer Research Foundation Inc been auto-revoked by the IRS?
- No. Damon Runyon Cancer Research Foundation Inc (EIN 13-1933825) does not appear on the IRS Auto-Revocation List. Givalgo Discover cross-references the IRS Auto-Revocation List on every profile load; if status changes, this page reflects it.
- Is Damon Runyon Cancer Research Foundation Inc listed in IRS Publication 78?
- Yes. Damon Runyon Cancer Research Foundation Inc is listed in IRS Publication 78 as an organisation eligible to receive tax-deductible charitable contributions. Pub 78 status is the canonical IRS signal that donations to an org are deductible.
